Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05327959 · ClinicalTrials.gov registry record · NA
A.L.P.S. Clavicle Plating System PMCF
A NA study of Clavicle Fracture and Clavicle Injury, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 5
- Study locations
NCT05327959 is a NA study of Clavicle Fracture and Clavicle Injury that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 98 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT05327959, a NA study of Clavicle Fracture and Clavicle Injury, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 5
- Study locations
Study Summary
A commercially available product clinical study which aims to confirm the safety, performance, and clinical benefits to the patient of the ALPS Clavicle Plating system for both the implant itself and the instrumentation used during surgery.
Conditions Studied
Interventions
- DEVICE Clavicle open reduction and internal fixation
Study Locations (5)
Florida
- Cleveland Clinic Florida - Weston
Michigan
- University of Michigan - Michigan Medicine - Ann Arbor
Oregon
- Slocum Research & Education Foundation - Eugene
Texas
- University of Texas San Antonio - San Antonio
Other
- General Foundation of the University of Valladolid - Valladolid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05327959
The ClinicalTrials.gov registry entry for NCT05327959 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Clavicle Fracture appearing as the primary indexed condition, and to 1 intervention - of which Clavicle open reduction and internal fixation is the first listed.
NCT05327959 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Michigan, Oregon.
Frequently Asked Questions
What is clinical trial NCT05327959 about?
NCT05327959 is a clinical study titled "A.L.P.S. Clavicle Plating System PMCF". A commercially available product clinical study which aims to confirm the safety, performance, and clinical benefits to the patient of the ALPS Clavicle Plating system for both the implant itself and the instrumentation used during surgery.
What is the current status of trial NCT05327959?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 98 participants. The study started on 2022-05-13. Estimated completion is 2027-03.
What conditions does trial NCT05327959 study?
This clinical trial studies the following conditions: Clavicle Fracture, Clavicle Injury.
What interventions are being tested in trial NCT05327959?
The interventions under investigation include: Clavicle open reduction and internal fixation (DEVICE).
Who is sponsoring clinical trial NCT05327959?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05327959 being conducted?
This trial has 5 study locations across Florida, Michigan, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clavicle Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.